[A favorable response to the granulocyte colony-stimulating factor in a patient with agranulocytosis associated with the use of intravenous immunoglobulin].

Subjects

Subjects :

Agranulocytosis etiology
Humans
Male
Middle Aged
Recombinant Proteins administration & dosage
Time Factors
Agranulocytosis drug therapy
Granulocyte Colony-Stimulating Factor administration & dosage
Immunoglobulins, Intravenous adverse effects

Details

Language :

Spanish; Castilian

ISSN :

0025-7753

Volume :

100

Issue :

9

Database :

MEDLINE

Journal :

Medicina clinica

Publication Type :

Report

Accession number :

7681134